MENU

Speakers


  • Mandy Jackson, Matthew Herper, Luke Timmerman

    Mandy Jackson, Matthew Herper, Luke Timmerman

    Mandy Jackson, US West Coast Editor, SCRIP Intelligence Matthew Herper, Senior Editor, Forbes Luke Timmerman, National Biotechnology

    BIOGRAPHY
  • Greg Verdine, PhD

    Greg Verdine, PhD

    CEO, Warp Drive Bio, Erving Professor of Chemistry, Harvard University

    BIOGRAPHY
  • Craig W. Lindsley, Ph.D.

    Craig W. Lindsley, Ph.D.

    Co-Director and Director of Medicinal Chemistry, Vanderbilt Center for Neuroscience Drug Discovery (VCNDD)

    BIOGRAPHY
  • Michelle Arkin, PhD

    Michelle Arkin, PhD

    Associate Director of Biology at the Small Molecule Discovery Center, Assistant Adjunct Professor in the Department of Pharmaceutical Chemistry at UCSF

    BIOGRAPHY
  • Deborah Dunsire, MD

    Deborah Dunsire, MD

    CEO, Forum Pharmaceuticals

    BIOGRAPHY
  • Jennifer Leeds, PhD

    Jennifer Leeds, PhD

    Executive Director in the Infectious Diseases Area, Novartis Institutes for BioMedical Research

    BIOGRAPHY
  • Alexander Kamb, Ph.D.

    Alexander Kamb, Ph.D.

    Senior Vice President, Research, Amgen

    BIOGRAPHY
  • Fiona Marshall, PhD

    Fiona Marshall, PhD

    Founder and CSO, Heptares Therapeutics

    BIOGRAPHY
  • Feng Zhang, Ph.D.

    Feng Zhang, Ph.D.

    Core Member, Broad Institute of MIT and Harvard; Investigator, McGovern Institute for Brain Research; W. M. Keck Career Development Professor in Biomedical Engineering, MIT

    BIOGRAPHY
  • Mark Murcko, Ph.D.

    Mark Murcko, Ph.D.

    Principal at Disruptive Biomedical, LLC, Professor of Practice at MIT & Northwestern

    BIOGRAPHY
  • Martin Burke , MD, PhD

    Martin Burke , MD, PhD

    Associate Professor of Chemistry, University of Illinois

    BIOGRAPHY
  • Susan Ward, PhD

    Susan Ward, PhD

    Executive Advisor to Life Sciences, Cure Duchenne

    BIOGRAPHY
  • Nick K. Terrett, Ph.D.

    Nick K. Terrett, Ph.D.

    Chief Scientific Officer, Ensemble Therapeutics

    BIOGRAPHY
  • Alexander Kamb, PhD

    Alexander Kamb, PhD

    Senior Vice President of Research, Amgen

    BIOGRAPHY
  • Andrew Hopkins, FRSC

    Andrew Hopkins, FRSC

    Chair of Medicinal Informatics and Professor of Translational Biology, University of Dundee

    BIOGRAPHY
  • Craig Webb, Ph.D.

    Craig Webb, Ph.D.

    Chief Scientific Officer, NuMedii

    BIOGRAPHY
  • Brent Stockwell, PhD

    Brent Stockwell, PhD

    Professor, Columbia University, Departments of Biological Sciences and Chemistry

    BIOGRAPHY
  • Martin Leach

    Martin Leach

    Vice President of R&D IT, Biogen-Idec

    BIOGRAPHY
  •  David Baker, PhD

    David Baker, PhD

    Professor of Biochemistry, University of Washington, Principal Investigator, Howard Hughes Med Ctr

    BIOGRAPHY
  • Michael A. Foley, Ph.D.

    Michael A. Foley, Ph.D.

    Director, Tri-I TDI

    BIOGRAPHY
  • Jay Bradner, MD

    Jay Bradner, MD

    Instructor in Medicine, Hematologic Neoplasia/Malignancies, Dana Farber Cancer Institute

    BIOGRAPHY
SEP 24, 2014

Advances in Drug Discovery and Development

Inaugural Virtual Symposium: September 24

Register for our free online event: Advances in Drug Discovery and Development.

On September 24, 2014, a world-class group of scientists from biotech, pharma and academia will present the latest research findings and new technologies that are driving the design, discovery and development of new drugs ? from small molecules and monoclonals to RNA therapeutics and gene-editing technologies.

We invite you to be a part of the inaugural C&EN virtual symposium and join a large anticipated audience of thousands of scientists eager to hear the latest science and trends in drug design and development. If you can?t make the live lectures, all presentations will be archived and available on demand for three months.

PROGRAM

Keynote and track speakers have driven R&D inside leading commercial and academic institutions, including Amgen, Biogen-Idec, Novartis, Columbia University, and Harvard/MIT. Hear what they have to say about the current state and future prospects of drug discovery, including:
* Next-gen medicines
* New gene targeting technologies
* Genomic applications
* Business strategies
* Informatics in the R&D environment

REGISTRATION

Register now for free, then log in on September 24 to visit the virtual conference and trade show. It's like being there but without the cost or hassle of travel.
* Participate in panel discussions and Q&A sessions
* "Walk the floor" in our virtual exhibition hall
* Live-chat with peers and vendors
* Download valuable resources
* Re-watch your favorite talks

The C&EN virtual symposium provides a perfect blend of interactivity and convenience. You can build your personal agenda ahead of time; if you are unable to hear a talk live, you can access recordings on demand for up to three months.
 


Speakers
  • Mandy Jackson, Matthew Herper, Luke Timmerman

    Mandy Jackson, US West Coast Editor, SCRIP Intelligence Matthew Herper, Senior Editor, Forbes Luke Timmerman, National Biotechnology
    BIOGRAPHY
  • Greg Verdine, PhD

    CEO, Warp Drive Bio, Erving Professor of Chemistry, Harvard University
    BIOGRAPHY
  • Craig W. Lindsley, Ph.D.

    Co-Director and Director of Medicinal Chemistry, Vanderbilt Center for Neuroscience Drug Discovery (VCNDD)
    BIOGRAPHY
  • Michelle Arkin, PhD

    Associate Director of Biology at the Small Molecule Discovery Center, Assistant Adjunct Professor in the Department of Pharmaceutical Chemistry at UCSF
    BIOGRAPHY
  • Deborah Dunsire, MD

    CEO, Forum Pharmaceuticals
    BIOGRAPHY
  • Jennifer Leeds, PhD

    Executive Director in the Infectious Diseases Area, Novartis Institutes for BioMedical Research
    BIOGRAPHY
  • Alexander Kamb, Ph.D.

    Senior Vice President, Research, Amgen
    BIOGRAPHY
  • Fiona Marshall, PhD

    Founder and CSO, Heptares Therapeutics
    BIOGRAPHY
  • Feng Zhang, Ph.D.

    Core Member, Broad Institute of MIT and Harvard; Investigator, McGovern Institute for Brain Research; W. M. Keck Career Development Professor in Biomedical Engineering, MIT
    BIOGRAPHY
  • Mark Murcko, Ph.D.

    Principal at Disruptive Biomedical, LLC, Professor of Practice at MIT & Northwestern
    BIOGRAPHY
  • Martin Burke , MD, PhD

    Associate Professor of Chemistry, University of Illinois
    BIOGRAPHY
  • Susan Ward, PhD

    Executive Advisor to Life Sciences, Cure Duchenne
    BIOGRAPHY
  • Nick K. Terrett, Ph.D.

    Chief Scientific Officer, Ensemble Therapeutics
    BIOGRAPHY
  • Alexander Kamb, PhD

    Senior Vice President of Research, Amgen
    BIOGRAPHY
  • Andrew Hopkins, FRSC

    Chair of Medicinal Informatics and Professor of Translational Biology, University of Dundee
    BIOGRAPHY
  • Craig Webb, Ph.D.

    Chief Scientific Officer, NuMedii
    BIOGRAPHY
  • Brent Stockwell, PhD

    Professor, Columbia University, Departments of Biological Sciences and Chemistry
    BIOGRAPHY
  • Martin Leach

    Vice President of R&D IT, Biogen-Idec
    BIOGRAPHY
  • David Baker, PhD

    Professor of Biochemistry, University of Washington, Principal Investigator, Howard Hughes Med Ctr
    BIOGRAPHY
  • Michael A. Foley, Ph.D.

    Director, Tri-I TDI
    BIOGRAPHY
  • Jay Bradner, MD

    Instructor in Medicine, Hematologic Neoplasia/Malignancies, Dana Farber Cancer Institute
    BIOGRAPHY

You May Also Like

Agenda

  • SEP 24, 2014 3:00 PM PDT

    Site-directed ligand discovery for cryptic sites and other challenging targets

    Michelle Arkin, PhD
    Associate Director of Biology at the Small Molecule Discovery Center, Assistant Adjunct Professor in the Department of Pharmaceutical Chemistry at UCSF
    BIOGRAPHY
  • SEP 24, 2014 2:00 PM PDT

    Design of protein structures, functions and assemblies

    David Baker, PhD
    Professor of Biochemistry, University of Washington, Principal Investigator, Howard Hughes Med Ctr
  • SEP 24, 2014 2:00 PM PDT

    Development and Applications of CRISPR-Cas9 for Genome Editing

    Feng Zhang, Ph.D.
    Core Member, Broad Institute of MIT and Harvard; Investigator, McGovern Institute for Brain Research; W. M. Keck Career Development Professor in Biomedical Engineering, MIT
    BIOGRAPHY
  • SEP 24, 2014 2:00 PM PDT

    Targeting Lysine Acetylation in Cancer

    Jay Bradner, MD
    Instructor in Medicine, Hematologic Neoplasia/Malignancies, Dana Farber Cancer Institute
    BIOGRAPHY
  • Evolve or die  a darwinian-like innovation process for technology
    SEP 24, 2014 1:00 PM PDT

    Evolve or die a darwinian-like innovation process for technology

    Martin Leach
    Vice President of R&D IT, Biogen-Idec
    BIOGRAPHY
  • Evolve or die a darwinian-like innovation process for technology
    SEP 24, 2014 1:00 PM PDT

    Evolve or die a darwinian-like innovation process for technology

    Martin Leach
    Vice President of R&D IT, Biogen-Idec
    BIOGRAPHY
  • SEP 24, 2014 1:00 PM PDT

    The VCNDD: CNS Drug Discovery in Academia

    Craig W. Lindsley, Ph.D.
    Co-Director and Director of Medicinal Chemistry, Vanderbilt Center for Neuroscience Drug Discovery (VCNDD)
    BIOGRAPHY
  • SEP 24, 2014 12:00 PM PDT

    Exploiting cell death for drug discovery

    Brent Stockwell, PhD
    Professor, Columbia University, Departments of Biological Sciences and Chemistry
    BIOGRAPHY
  • SEP 24, 2014 12:00 PM PDT

    The Accurate Prediction of Ligand Binding Free Energies

    Mark Murcko, Ph.D.
    Principal at Disruptive Biomedical, LLC, Professor of Practice at MIT & Northwestern
    BIOGRAPHY
  • SEP 24, 2014 11:45 AM PDT

    The Business of Biotech

    Mandy Jackson, Matthew Herper, Luke Timmerman
    Mandy Jackson, US West Coast Editor, SCRIP Intelligence Matthew Herper, Senior Editor, Forbes Luke Timmerman, National Biotechnology
    BIOGRAPHY
  • SEP 24, 2014 11:00 AM PDT

    Drug Repositioning in the Era of Personalized Medicine

    Craig Webb, Ph.D.
    Chief Scientific Officer, NuMedii
    BIOGRAPHY
  • SEP 24, 2014 11:00 AM PDT

    Structure based Drug Design for G-protein coupled receptors using the StaR(r) technology

    Fiona Marshall, PhD
    Founder and CSO, Heptares Therapeutics
    BIOGRAPHY
  • SEP 24, 2014 10:00 AM PDT

    Keynote, The Promises and Challenges of Next-Generation Therapeutics

    Greg Verdine, PhD
    CEO, Warp Drive Bio, Erving Professor of Chemistry, Harvard University
    BIOGRAPHY
  • SEP 24, 2014 10:00 AM PDT

    The Promises and Challenges of Next-Generation Therapeutics

    Greg Verdine, PhD
    CEO, Warp Drive Bio, Erving Professor of Chemistry, Harvard University
    BIOGRAPHY
  • SEP 24, 2014 8:00 AM PDT

    Approaches to antibacterial discovery: New strategies and technologies to address a challenging field

    Jennifer Leeds, PhD
    Executive Director in the Infectious Diseases Area, Novartis Institutes for BioMedical Research
    BIOGRAPHY
  • SEP 24, 2014 8:00 AM PDT

    Role of Academic Institutions in Target Selection

    Michael A. Foley, Ph.D.
    Director, Tri-I TDI
    BIOGRAPHY
  • SEP 24, 2014 7:00 AM PDT

    Making molecular prosthetics

    Martin Burke , MD, PhD
    Associate Professor of Chemistry, University of Illinois
    BIOGRAPHY
  • SEP 24, 2014 6:00 AM PDT

    Attacking Dementias Moving from symptoms to causes the advance of precision medicine

    Deborah Dunsire, MD
    CEO, Forum Pharmaceuticals
    BIOGRAPHY
  • SEP 24, 2014 6:00 AM PDT

    Translational Medicine for Rare Disease: Lessons from Duchenne Muscular Dystrophy

    Susan Ward, PhD
    Executive Advisor to Life Sciences, Cure Duchenne
    BIOGRAPHY
  • SEP 24, 2014 5:00 AM PDT

    Algorithmic Drug Design (Prerecorded)

    Andrew Hopkins, FRSC
    Chair of Medicinal Informatics and Professor of Translational Biology, University of Dundee
    BIOGRAPHY
  • SEP 24, 2014 5:00 AM PDT

    Exploring macrocycles for drug discovery: Novel lead series for challenging protein-protein interactions

    Nick K. Terrett, Ph.D.
    Chief Scientific Officer, Ensemble Therapeutics
    BIOGRAPHY
  • Informatics/In silico Design
  • SEP 24, 2014 5:00 AM PDT

    Algorithmic Drug Design (Prerecorded)

    Andrew Hopkins, FRSC
    Chair of Medicinal Informatics and Professor of Translational Biology, University of Dundee
    BIOGRAPHY
  • SEP 24, 2014 11:00 AM PDT

    Drug Repositioning in the Era of Personalized Medicine

    Craig Webb, Ph.D.
    Chief Scientific Officer, NuMedii
    BIOGRAPHY
  • SEP 24, 2014 12:00 PM PDT

    Exploiting cell death for drug discovery

    Brent Stockwell, PhD
    Professor, Columbia University, Departments of Biological Sciences and Chemistry
    BIOGRAPHY
  • Evolve or die  a darwinian-like innovation process for technology
    SEP 24, 2014 1:00 PM PDT

    Evolve or die a darwinian-like innovation process for technology

    Martin Leach
    Vice President of R&D IT, Biogen-Idec
    BIOGRAPHY
  • SEP 24, 2014 2:00 PM PDT

    Design of protein structures, functions and assemblies

    David Baker, PhD
    Professor of Biochemistry, University of Washington, Principal Investigator, Howard Hughes Med Ctr
  • Drug Discovery
  • SEP 24, 2014 5:00 AM PDT

    Exploring macrocycles for drug discovery: Novel lead series for challenging protein-protein interactions

    Nick K. Terrett, Ph.D.
    Chief Scientific Officer, Ensemble Therapeutics
    BIOGRAPHY
  • SEP 24, 2014 6:00 AM PDT

    Translational Medicine for Rare Disease: Lessons from Duchenne Muscular Dystrophy

    Susan Ward, PhD
    Executive Advisor to Life Sciences, Cure Duchenne
    BIOGRAPHY
  • SEP 24, 2014 7:00 AM PDT

    Making molecular prosthetics

    Martin Burke , MD, PhD
    Associate Professor of Chemistry, University of Illinois
    BIOGRAPHY
  • SEP 24, 2014 10:00 AM PDT

    Keynote, The Promises and Challenges of Next-Generation Therapeutics

    Greg Verdine, PhD
    CEO, Warp Drive Bio, Erving Professor of Chemistry, Harvard University
    BIOGRAPHY
  • SEP 24, 2014 1:00 PM PDT

    The VCNDD: CNS Drug Discovery in Academia

    Craig W. Lindsley, Ph.D.
    Co-Director and Director of Medicinal Chemistry, Vanderbilt Center for Neuroscience Drug Discovery (VCNDD)
    BIOGRAPHY
  • SEP 24, 2014 3:00 PM PDT

    Site-directed ligand discovery for cryptic sites and other challenging targets

    Michelle Arkin, PhD
    Associate Director of Biology at the Small Molecule Discovery Center, Assistant Adjunct Professor in the Department of Pharmaceutical Chemistry at UCSF
    BIOGRAPHY
  • Drug Development
  • SEP 24, 2014 6:00 AM PDT

    Attacking Dementias Moving from symptoms to causes the advance of precision medicine

    Deborah Dunsire, MD
    CEO, Forum Pharmaceuticals
    BIOGRAPHY
  • SEP 24, 2014 8:00 AM PDT

    Approaches to antibacterial discovery: New strategies and technologies to address a challenging field

    Jennifer Leeds, PhD
    Executive Director in the Infectious Diseases Area, Novartis Institutes for BioMedical Research
    BIOGRAPHY
  • SEP 24, 2014 11:00 AM PDT

    Structure based Drug Design for G-protein coupled receptors using the StaR(r) technology

    Fiona Marshall, PhD
    Founder and CSO, Heptares Therapeutics
    BIOGRAPHY
  • SEP 24, 2014 2:00 PM PDT

    Development and Applications of CRISPR-Cas9 for Genome Editing

    Feng Zhang, Ph.D.
    Core Member, Broad Institute of MIT and Harvard; Investigator, McGovern Institute for Brain Research; W. M. Keck Career Development Professor in Biomedical Engineering, MIT
    BIOGRAPHY
  • Cancer
  • SEP 24, 2014 8:00 AM PDT

    Role of Academic Institutions in Target Selection

    Michael A. Foley, Ph.D.
    Director, Tri-I TDI
    BIOGRAPHY
  • SEP 24, 2014 2:00 PM PDT

    Targeting Lysine Acetylation in Cancer

    Jay Bradner, MD
    Instructor in Medicine, Hematologic Neoplasia/Malignancies, Dana Farber Cancer Institute
    BIOGRAPHY
  • Keynote
  • SEP 24, 2014 10:00 AM PDT

    The Promises and Challenges of Next-Generation Therapeutics

    Greg Verdine, PhD
    CEO, Warp Drive Bio, Erving Professor of Chemistry, Harvard University
    BIOGRAPHY
  • Panel Discussion
  • SEP 24, 2014 11:45 AM PDT

    The Business of Biotech

    Mandy Jackson, Matthew Herper, Luke Timmerman
    Mandy Jackson, US West Coast Editor, SCRIP Intelligence Matthew Herper, Senior Editor, Forbes Luke Timmerman, National Biotechnology
    BIOGRAPHY
  • Technology Development
  • SEP 24, 2014 12:00 PM PDT

    The Accurate Prediction of Ligand Binding Free Energies

    Mark Murcko, Ph.D.
    Principal at Disruptive Biomedical, LLC, Professor of Practice at MIT & Northwestern
    BIOGRAPHY
  • Evolve or die a darwinian-like innovation process for technology
    SEP 24, 2014 1:00 PM PDT

    Evolve or die a darwinian-like innovation process for technology

    Martin Leach
    Vice President of R&D IT, Biogen-Idec
    BIOGRAPHY

Sponsors & Partners

For information on becoming a sponsor or exhibitor, please click here.


Help

Loading Comments...